Yestar Healthcare Holdings Company Limited announced that Mr. Li Bin has been appointed as an executive Director of the Company with effect from 18 June 2021. Mr. Li, aged 48, joined the Group in August 2015 as the chief executive officer of a non-wholly owned subsidiary of the Company. Mr. Li is the founder of Shanghai Emphasis Investment Management Consulting Co. Ltd. Mr. Li is primarily responsible for the development of the overall strategy and the formation of strategic goals of Shanghai Anbaida, as well as the supervision and management of Shanghai Anbaida's sales. Mr. Li shall hold office until the next general meeting of the Company and will be eligible for and subject to re-election at such meeting in accordance with the articles of association of the Company.